English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 7 March 2011, 15:00 HKT/SGT
Share:
    

Source: CMS
China Medical System Accredited by 'China's Top 100 Potential Enterprises' by Forbes China for Two Consecutive Years

HONG KONG, Mar 7, 2011 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Company", SEHK: 867), a leading China-based pharmaceutical services company focusing on the marketing, promotion and sale of prescription drugs, is pleased to announce that the Company was accredited as "China's Top 100 Potential Enterprises" among the list compiled by the Forbes China in February 2011. CMS has been selected on the list for two consecutive years.

Compiled by Forbes China, the "China's Top 100 Potential Enterprises" list focuses on the SMEs in China, and is the first ranking of its kind to cover the SMEs across all industries. This is the second consecutive year that CMS has won the coveted accolade for its outstanding business performance and contribution to the development of China's SMEs, and for its efforts to strive for excellence in its field.

About "China's Top 100 Potential Enterprises" by Forbes China
http://www.forbeschina.com/list/1008/more

Contact:
Hill and Knowlton Asia Ltd.

Crystal Yip  
Tel: +852 2894 6211 / 9720 6445
Email: crystal.yip@hillandknowlton.com.hk

James Wong
Tel: +852 2894 6216 / 9300 2263
Email: james.wong@hillandknowlton.com.hk



Topic: Awards
Source: CMS

Sectors: BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

CMS Related News
Oct 21, 2024 19:18 HKT/SGT
康哲藥業入選2024年度「中國醫藥上市公司ESG競爭力」系列榜單
Oct 18, 2024 14:54 HKT/SGT
康哲藥業:蘆可替尼乳膏(白癜風)大灣區首批處方落地
Sept 24, 2024 21:46 HKT/SGT
康哲藥業:磷酸蘆可替尼乳膏(白癜風)中國上市許可申請已獲受理
Apr 1, 2024 20:30 HKT/SGT
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Aug 13, 2020 08:57 HKT/SGT
康哲药业控股有限公司2020年中期业绩公布
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575